Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches-Reference-Cited by-同舟云学术

Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches

Published:2017 Issue: Volume: Page:115-146
ISSN:0171-2004
Container-title:Gastrointestinal Pharmacology
language:
Short-container-title:

Author:

Abraham Bincy P.,Ahmed Tasneem,Ali Tauseef

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/164_2016_122

Reference113 articles.

1. Abegunde AT, Muhammad BH, Bhatti O, Ali T (2016) Environmental risk factors for inflammatory bowel diseases: evidence based literature review. World J Gastroenterol 22(27):6296–317

2. Abreu MT, Fukata M, Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 174:4453–4460

3. Akerkar GA, Peppercorn MA, Hamel MB (1997) Corticosteroid-associated complications in elderly Crohn’s disease patients. Am J Gastroenterol 92:461–464

4. Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT (2012) Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology 142:482–489

5. Andrews WW et al (2003) Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol 101:847–855

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging insights into traditional Chinese medicine associated with neurodegenerative diseases: A bibliometric analysis;Journal of Ethnopharmacology;2025-01

2. Optimization of transplantation methods using isolated mesenchymal stem/stromal cells: clinical trials of inflammatory bowel diseases as an example;Inflammation and Regeneration;2024-08-16

3. Harnessing nature’s pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis;Frontiers in Pharmacology;2024-08-14

4. Molecular targets associated with ulcerative colitis and the benefits of atractylenolides-based therapy;Frontiers in Pharmacology;2024-05-27

5. Pomegranate seed oil mitigates liver and kidney damage in an experimental colitis model: Modulation of NF-κB activation and apoptosis;Prostaglandins & Other Lipid Mediators;2024-04